Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism

Parkinson’s disease (PD) is a neurodegenerative disorder of unknown etiology. The main treatment of PD consists of medication with dopamine-based drugs, which palliate the symptoms but may produce adverse effects after chronic administration. Accordingly, there is a need to develop novel neuroprotec...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Soler, Maricel, Cordobilla, Begoña, Morató, Xavier, Fernández-Dueñas, Víctor, Domingo, Joan C., Ciruela, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127646/
https://www.ncbi.nlm.nih.gov/pubmed/30233293
http://dx.doi.org/10.3389/fnins.2018.00604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127646/
https://www.ncbi.nlm.nih.gov/pubmed/30233293
http://dx.doi.org/10.3389/fnins.2018.00604

Ejemplares similares